CIAS
MRNA icon

CFS Investment Advisory Services’s Moderna MRNA Stock Holding History

CFS Investment Advisory Services’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-14,190
Closed – – 211
2022
Q3 		$0 Buy
+14,190
New +$2.15M ﹤0.01% 318
2022
Q2 		– Sell
-13,609
Closed – – 414
2022
Q1 		$0 Buy
13,609
+11,835
+667% +$1.99M ﹤0.01% 500
2021
Q4 		$300K Buy
1,774
+431
+32% +$126K 0.04% 192
2021
Q3 		$517K Buy
+1,343
New +$495K 0.07% 156

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

CFS Investment Advisory Services's MRNA Position: Q4 2022 in Review

CFS Investment Advisory Services sold out of Moderna (MRNA) in Q4 2022, closing a stake of 14,190 shares.

CFS Investment Advisory Services first reported a position in MRNA in Q3 2021 and held it in 4 quarters. The position peaked at $517K in Q3 2021. 1,071 funds tracked by Wall St. Rank hold MRNA as of Q4 2022.

  • CFS Investment Advisory Services reported no remaining Moderna position as of Q4 2022 after selling out during the quarter.
  • CFS Investment Advisory Services sold 14,190 Moderna shares in Q4 2022.
  • CFS Investment Advisory Services first reported a position in Moderna in Q3 2021 and held it in 4 quarters.
  • CFS Investment Advisory Services's Moderna position peaked at $517K in Q3 2021.
  • 1,071 funds tracked by Wall St. Rank held Moderna as of Q4 2022.

Based on CFS Investment Advisory Services's 13F filing for Q4 2022, filed 13 Feb 2023.